Security key
45826J105
Intellia Therapeutics, Inc. - COMMON STOCK (NTLA)
CUSIP: 45826J105
Q3 2019 13F Holders as of 30 Sep 2019
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 44,102,636
- Total 13F value
- $588,745,766
- Share change
- +5,283,984
- Put/Call ratio
- 41%
- SEC-reported price per share
- $13.35
- Number of holders
- 131
- Value change
- +$69,153,421
- Number of buys
- 57
- Number of sells
- 54
- Shares outstanding
- 135,808,632
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2019
Institutions
131
Top holders
10
NTLA full security history
Ownership snapshot
Full 13F holder table
Intellia Therapeutics, Inc. SEC filings
Intellia Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of NTLA - Intellia Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARK Investment Management...
Disclosed value leader
ARK Investment Management...
Comparable rows
15/15
Latest evidence
30 Jun 2019
13F
Lead comparable stake: 6.1%
Showing 1-6 of 15 holder rows.
Quick read
ARK Investment Management LLC leads the comparable SEC ownership view at 6.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARK Investment Management LLC's linked filing trail.
Comparable ownership
Top 5
ARK Investment Management LLC
6.1%
Amova Asset Management Americas, ...
3.8%
BlackRock Finance, Inc.
2.5%
VANGUARD GROUP INC
2.3%
Sumitomo Mitsui Trust Group, Inc.
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
Company
|
6.1%
|
$134,941,000
8,243,165 shares
|
— | 30 Jun 2019 |
| Amova Asset Management Americas, Inc. |
13F
Company
|
3.8%
|
$84,487,000
5,161,098 shares
|
— | 30 Jun 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
2.5%
|
$55,499,000
3,390,267 shares
|
— | 30 Jun 2019 |
| VANGUARD GROUP INC |
13F
Company
|
2.3%
|
$52,124,000
3,184,116 shares
|
— | 30 Jun 2019 |
| Sumitomo Mitsui Trust Group, Inc. |
13F
Company
|
1.6%
|
$36,287,000
2,216,660 shares
|
— | 30 Jun 2019 |
| FMR LLC |
13F
Company
|
1.5%
|
$34,388,000
2,100,646 shares
|
— | 30 Jun 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
131
Shares
44,102,636
Rows available
131
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
142
Q3 2019 holders
131
Holder diff
-11
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 value | Q3 2019 value | Value change | Value Chg % |
|---|